Kidney research, 2026-09-12

Today brought background science on kidney protection, not new results to act on.

• Article A Slowing decline
  A strong review confirms SGLT2 inhibitor drugs protect the kidneys and heart in type 2 diabetes even when blood sugar is not very high, which suggests they work through more than sugar control.
• Paper A Nutrition & lifestyle
  A review of lifestyle programs built around a person's own culture looked at how well they lower blood pressure, one of the best long term ways to protect kidneys, but the available text gives no combined numbers.
• Article C Mind-body
  A study of 107 people on dialysis measured depression and anxiety, a reminder that mood is a real part of kidney care, though this kind of study can only show links and the final rates were not available.
• Article C Slowing decline
  Most of the rest of today was lab work, animal studies and one time snapshots, so nothing here is strong enough to change what you do.

Today's sweep was light, and most of it explained how things work rather than showing what happens to patients. The one high grade item with hard outcomes was a summary of past SGLT2 inhibitor trials, which is worth knowing if you and your doctor have discussed those drugs, but it is not new evidence. The blood pressure review points in a helpful direction without giving a size to the benefit. Two transplant studies and a gum disease study rounded out the day, all observational, meaning they spot patterns rather than prove causes.